Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05984849 · ClinicalTrials.gov registry record · NA

Playing Game to Learn About Children's Vaccine Project

A NA study of Hpv and Vaccine-Preventable Diseases, sponsored by Michigan State University.

Recruiting
Registry status
NA
Development phase
180
Enrollment target
1
Study location

NCT05984849 is a NA study of Hpv and Vaccine-Preventable Diseases that is actively recruiting participants, run by Michigan State University. The registered enrollment target is 180 participants, below the 2,234-participant average among 24 other Hpv trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05984849, a NA study of Hpv and Vaccine-Preventable Diseases, is actively recruiting participants, sponsored by Michigan State University.

RECRUITING
Registry status
NA
Development phase
180 participants
Enrollment target
1
Study location

Study Summary

This proposed study aims to conduct timely research that promotes vaccine confidence and vaccination of one strongly recommended vaccine with suboptimal uptake rates: Human papillomavirus (HPV) in vulnerable and underserved youth aged 11-14.

Interventions

  • BEHAVIORAL vaccination game

Study Locations (1)

Arizona

  • Community - Chandler

Trial Details

FieldValue
Enrollment Target 180 participants
Start Date 2025-09
Est. Completion 2027-08
Phase NA

Sponsor

Michigan State University

120 total trials

What the Registry Record Tells You About NCT05984849

The ClinicalTrials.gov registry entry for NCT05984849 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,234-participant average among 24 other Hpv trials with a reported enrollment target (92% lower). The listed sponsor is Michigan State University, which has 120 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Hpv appearing as the primary indexed condition, and to 1 intervention - of which vaccination game is the first listed.

NCT05984849 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.

Frequently Asked Questions

What is clinical trial NCT05984849 about?

NCT05984849 is a clinical study titled "Playing Game to Learn About Children's Vaccine Project". This proposed study aims to conduct timely research that promotes vaccine confidence and vaccination of one strongly recommended vaccine with suboptimal uptake rates: Human papillomavirus (HPV) in vulnerable and underserved youth aged 11-14.

What is the current status of trial NCT05984849?

This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2025-09. Estimated completion is 2027-08.

What conditions does trial NCT05984849 study?

This clinical trial studies the following conditions: Hpv, Vaccine-Preventable Diseases.

What interventions are being tested in trial NCT05984849?

The interventions under investigation include: vaccination game (BEHAVIORAL).

Who is sponsoring clinical trial NCT05984849?

This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05984849 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hpv

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.